News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
487,990 Results
Type
Article (32044)
Company Profile (56)
Press Release (455890)
Section
Business (147277)
Career Advice (1762)
Deals (24778)
Drug Delivery (65)
Drug Development (61740)
Employer Resources (113)
FDA (11885)
Job Trends (10745)
News (249910)
Policy (23324)
Tag
Academia (2172)
Alliances (39331)
Alzheimer's disease (1133)
Approvals (11865)
Artificial intelligence (132)
Bankruptcy (227)
Best Places to Work (8907)
Breast cancer (161)
Cancer (1183)
Cardiovascular disease (107)
Career advice (1476)
Cell therapy (248)
Clinical research (49264)
Collaboration (456)
Compensation (141)
COVID-19 (1829)
C-suite (84)
Data (1275)
Diabetes (164)
Diagnostics (4518)
Earnings (62082)
Employer resources (100)
Events (72947)
Executive appointments (328)
FDA (12477)
Funding (372)
Gene therapy (194)
GLP-1 (504)
Government (3260)
Healthcare (14254)
Infectious disease (1904)
Inflammatory bowel disease (87)
Interviews (310)
IPO (12264)
Job creations (2191)
Job search strategy (1250)
Layoffs (261)
Legal (5537)
Lung cancer (171)
Lymphoma (85)
Manufacturing (148)
Medical device (9425)
Medtech (9429)
Mergers & acquisitions (12753)
Metabolic disorders (421)
Neuroscience (1408)
NextGen: Class of 2025 (4793)
Non-profit (3580)
Northern California (1381)
Obesity (222)
Opinion (166)
Patents (101)
People (37913)
Phase I (14839)
Phase II (21698)
Phase III (16698)
Pipeline (534)
Postmarket research (2197)
Preclinical (6744)
Radiopharmaceuticals (200)
Rare diseases (225)
Real estate (3338)
Regulatory (15704)
Research institute (1816)
Resumes & cover letters (276)
Southern California (1208)
Startups (2269)
United States (12212)
Vaccines (414)
Weight loss (158)
Date
Today (103)
Last 7 days (691)
Last 30 days (1585)
Last 365 days (26725)
2025 (1061)
2024 (26875)
2023 (30155)
2022 (38013)
2021 (41136)
2020 (39965)
2019 (34546)
2018 (26022)
2017 (24146)
2016 (23286)
2015 (27347)
2014 (21917)
2013 (18668)
2012 (19081)
2011 (18739)
2010 (17550)
Location
Africa (625)
Arizona (95)
Asia (27224)
Australia (4802)
California (3080)
Canada (1123)
China (264)
Colorado (138)
Connecticut (162)
Europe (62550)
Florida (476)
Georgia (117)
Illinois (307)
Indiana (196)
Japan (80)
Maryland (481)
Massachusetts (2295)
Michigan (134)
Minnesota (188)
New Jersey (949)
New York (947)
North Carolina (623)
Northern California (1381)
Ohio (118)
Pennsylvania (726)
South America (882)
Southern California (1208)
Texas (454)
Utah (93)
Washington State (343)
487,990 Results for "crg and associates llc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
T2 Biosystems Announces CRG’s Conversion from Preferred Stock to Common Stock - May 14, 2024
T2 Biosystems, Inc., a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced that entities affiliated with CRG Servicing LLC have converted Series A and Series B Convertible Preferred Stock to Common Stock.
May 14, 2024
·
4 min read
Genetown
T2 Biosystems Announces Agreement with CRG for the Conversion of $15 Million of CRG Term Loan into Equity
T2 Biosystems, Inc. announced the entrance into a definitive agreement to convert $15 million of its term loan with entities affiliated with CRG Servicing LLC into T2 Biosystems equity upon stockholder approval.
February 15, 2024
·
5 min read
Genetown
T2 Biosystems Announces the Conversion of an Additional $15 Million of CRG Term Loan into Equity
T2 Biosystems, Inc., a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced the conversion of an additional $15 million of its term loan with entities affiliated with CRG Servicing LLC into T2 Biosystems equity.
May 6, 2024
·
4 min read
Biotech Bay
Avinger Announces Conversion of $11 Million of CRG Debt into Preferred Equity
Avinger, Inc. announced the conversion of $11 million or approximately 80% of its existing debt with entities affiliated with CRG Partners III L.P. into a shares of a new series of convertible preferred stock.
May 16, 2024
·
3 min read
Press Releases
CARGO Therapeutics Announces ASH 2024 Abstract on CRG-023, a Tri-specific CAR T, Highlighting Innovative Construct Design and Durable Anti-B-Cell Lymphoma Activity
November 5, 2024
·
10 min read
Press Releases
Cycle Pharma Acquires Banner Life Sciences, LLC
January 13, 2025
·
17 min read
Genetown
T2 Biosystems Announces Conversion of Approximately Twenty Percent of CRG Term Loan into Equity
T2 Biosystems, Inc., a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced the conversion of approximately 20% of its term loan with entities affiliated with CRG Servicing LLC into T2 Biosystems common stock and Series B convertible preferred stock.
July 6, 2023
·
4 min read
Business
Andelyn Biosciences and Grace Science, LLC Partner to Tech Transfer Phase I/II/III Manufacturing of a Suspension Process Adeno-Associated Virus (AAV) Gene Therapy for NGLY1 Deficiency
Andelyn Biosciences has partnered with Grace Science, LLC, to tech transfer and manufacture GS-100, a suspension process AAV NGLY1 gene therapy for Phase I/II/III clinical trial material for the treatment of NGLY1 Deficiency.
March 25, 2024
·
3 min read
Biotech Bay
Avinger Announces Conversion of 12% of CRG Term Debt into Equity
Avinger, Inc. announced the conversion of approximately 12% of its existing debt with entities affiliated with CRG Partners III L.P. into shares of a new series of convertible preferred stock.
August 4, 2023
·
3 min read
Press Releases
Marius Pharmaceuticals Partners with US Specialists Management, LLC (“USSM”) Through Affiliated Urologic In-office Dispensaries
January 14, 2025
·
7 min read
1 of 48,799
Next
